Chemotherapy and Unrelated Donor SCT for Blood and Immune System Cancers

Request Access

Anthropometry (1)

WEIGHT - Subject's weight (phv00430460.v1.p1)

Demographics (3)

AGE - Subject age at enrollment (phv00430457.v1.p1)
COLLECTION_DATE - Collection date (days after transplant) (phv00430473.v1.p1)
SEX - Self-reported sex (phv00430455.v1.p1)

Disease Events (1)

AFFECTION_STATUS - Subject case-control status for Graft-versus-Host disease (GvHD) (phv00430454.v1.p1)

Race and Ethnicity (1)

RACE - Self-reported race (phv00430456.v1.p1)

Other (21)

ACUTE_GVHD_DIAGNOSIS - Official acute GVHD diagnosis date (days post transplant) (phv00430467.v1.p1)
ACUTE_GVHD_ONSET - First symptoms of acute GvHD (days post-transplant) (phv00430468.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00430472.v1.p1)
BODY_SITE - Body site where sample was collected (phv00430471.v1.p1)
CONDITIONING - Conditioning regimen pre-transplant (RIC= reduced intensity conditioning) (phv00430465.v1.p1)
CONSENT - Consent group as determined by DAC (phv00430450.v1.p1)
GRAFT_AGE - Donor age (years) (phv00430463.v1.p1)
GRAFT_SOURCE - Graft source for HSCT (PBSC = peripheral blood stem cells; BM = bone marrow) (phv00430461.v1.p1)
GRAFT_TYPE - Donor source/graft type (phv00430462.v1.p1)
GVHD_ORGAN_INVOLVEMENT - Tissues affected by GVHD (phv00430469.v1.p1)
INDICATION_FOR_TRANSPLANT - Reason for transplant (phv00430458.v1.p1)
INDICATION_ONSET - Indication onset (age at onset of disease that is the reason for the transplant) (phv00430459.v1.p1)
MATCH - Haplotype match with donor/recipient (phv00430464.v1.p1)
PROPHYLAXIS - Treatment regimen for GVHD prophylaxis (TMS = Tacrolimus/Methotrexate/Sirolimus; AC = Alemtuzumab/Cyclosporin) (phv00430466.v1.p1)
SAMPLE_ID - Sample ID (phv00430470.v1.p1)
SAMPLE_ID - Sample ID (phv00430452.v1.p1)
SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00430475.v1.p1)
SUBJECT_ID - Subject ID (phv00430453.v1.p1)
SUBJECT_ID - Subject ID (phv00430449.v1.p1)
SUBJECT_ID - Subject ID (phv00430451.v1.p1)
SYMPTOM_PRESENT - Presence of symptoms at day of collection (phv00430474.v1.p1)